Progyny (PGNY) Net Income towards Common Stockholders (2018 - 2026)

Progyny (PGNY) has 9 years of Net Income towards Common Stockholders data on file, last reported at $24.2 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 60.59% year-over-year to $24.2 million in Q1 2026; TTM through Mar 2026 was $67.6 million, a 28.85% increase from a year earlier, with the FY2025 full-year figure at $58.5 million, up 7.7% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $24.2 million, up from $12.5 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for PGNY reached as high as $24.2 million in Q1 2026 and fell as low as $3.4 million in Q4 2022.
• Historically, Net Income towards Common Stockholders has averaged $13.5 million across 5 years, with a median of $13.9 million in 2025.
• Across the five-year window, Net Income towards Common Stockholders plunged 77.4% in 2022 and surged 295.25% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at $3.4 million in 2022, then jumped by 295.25% to $13.5 million in 2023, then declined by 21.81% to $10.5 million in 2024, then grew by 18.54% to $12.5 million in 2025, then surged by 93.7% to $24.2 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $24.2 million in Q1 2026, $12.5 million in Q4 2025, and $13.9 million in Q3 2025.